|
|
 |
|
Mardi 9 Février
| Heure: |
13:00 - 14:00 |
| Lieu: |
Séminaire en ligne. |
| Résumé: |
MB - Personalised risk predictor for acute cellular rejection in lung transplantation - |
| Description: |
Ian Morilla & Alexy Tran DinhLung transplantation is the treatment of last resort that may be offered
to selected patients with end-stage pulmonary disease. Acute cell
rejection (ACR) is common complication that have nearly the 30% of lung
transplant recipients within the first year of follow-up. The
development of surrogate markers that could help identify recipients at
risk of developing ACR would be a major diagnostic aid to the clinician.
CD31, the receptor most represented on the endothelial surface, is
cleaved and released into the plasma upon endothelial activation and is
therefore a powerful biomarker of endothelial dysfunction. |
|
|
